SLACK, Inc.

SHERPA: Unknown

People

  1. Brennan
    Brennan
  2. Abramson
    Abramson
  3. Francis
    Francis
  4. Boland
    Boland
  5. Canestraro
    Canestraro
  6. Davis
    Davis
  7. Dunkel
    Dunkel
  8. Groeger
    Groeger
  9. Guarini
    Guarini
  10. Healey
    Healey

Groups

  1. Surgery (35)
  2. Sarcoma Surgeons (14)
  3. Molecular Pharmacology and Chemistry Program Faculty (12)
  4. Sloan Kettering Institute Faculty (12)
  5. Pediatrics, Department of (10)
  6. Nursing (8)
  7. Orthopaedic Service (2)
  8. Department of Medicine (1)
  9. Division of Subspecialty Medicine (1)
  10. Gastroenterology, Hepatology and Nutrition (1)
Search Within
  1. "Surgery"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (5)
  3. Miscellaneous (5)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Surgery (35)
  2. Sarcoma Surgeons (14)
  3. Molecular Pharmacology and Chemistry Program Faculty (12)
  4. Sloan Kettering Institute Faculty (12)
  5. Pediatrics, Department of (10)
  6. Nursing (8)

More Groups

People
  1. Murray Brennan (12)
  2. John Lewis (11)
  3. Maurie Markman (11)
  4. Stephen Rubin (11)
  5. Thomas Hakes (11)
  6. William Hoskins (11)

More People

Years
  1. 2025 (3)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (1)
  5. 2017 (1)
  6. 2016 (1)

More Years

Publications
  1. Clinical Research (23)
  2. Journal of Pediatric Ophthalmology and Strabismus (10)
  3. Orthopedics (2)

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiple day intraperitoneal (IP) treatment of refractory ovarian cancer employing a regimen of cisplatin (DDP) and cytarabine (ACA-C)
    Meeting Abstract

    Markman, M.; Hakes, T.; Reichman, B.; Hoskins, W.; Rubin, S.; Jones, W.; Almadrones, L.; Yordan, E. L. Jr; Eriksson, J.; Lewis, J. L. Jr
    Clinical Research (1990)

    Fulltext@MSK | Save
  • A randomized double-blind-study of L carnitine therapy in patients on home parenteral nutrition (HTPN) with low plasma carnitine levels
    Meeting Abstract

    Steephen, A.; Larchian, W.; Berner, Y.; Nicora, R.; Brennan, M.; Shike, M.
    Clinical Research (1990)

    Fulltext@MSK | Save
  • Alterations in hepatic diacylglycerol levels in tumor-bearing rats
    Meeting Abstract

    Andrade, L.; Tolvo, A.; Vydelingum, N. A.; Brennan, M. F.
    Clinical Research (1990)

    Fulltext@MSK | Save
  • Amino acid infusion reduces insulin mediated glucose disposal in normal man
    Meeting Abstract

    Pisters, P. W. T.; Restifo, N. P.; Cersosimo, E.; Brennan, M. F.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • The use of the blood gas analyzer in indirect calorimetry
    Meeting Abstract

    Restifo, N. P.; Pisters, P. W. T.; Brennan, M. F.
    Clinical Research (1989)

    Fulltext@MSK | Save
  • Non-invasive assessment of wound healing in patients following extremity soft tissue sarcoma excision and adjuvant brachytherapy
    Meeting Abstract

    Conlon, K. C.; Posner, M. C.; DiResta, G. R.; Brennan, M. F.
    Clinical Research (1988)

    Fulltext@MSK | Save
  • Combination intraperitoneal (IP) chemotherapy of refractory/recurrent ovarian carcinoma (ROC) employing a regimen of cisplatin (C) and etoposide (E): A phase 2 trial
    Meeting Abstract

    Markman, M.; Reichman, B.; Hakes, T.; Rubin, S.; Hoskins, W.; Lewis, J. L.
    Clinical Research (1988)

    Fulltext@MSK | Save
  • Lack of efficacy of recombinant gamma-interferon (rGI) administered by the intraperitoneal (IP) route as therapy of refractory ovarian carcinoma (ROC)
    Meeting Abstract

    Markman, M.; D'Acquisto, R.; Hakes, T.; Rubin, S.; Hoskins, W.; Lewis, J. L. Jr
    Clinical Research (1987)

    Fulltext@MSK | Save
  • Recombinant gamma-interferon (rGI) administered by the intraperitoneal (IP) route as treatment of refractory ovarian carcinoma (ROC)
    Meeting Abstract

    D'Acquisto, R.; Markman, M.; Hakes, T.; Rubin, S.; Hoskins, W.; Lewis, J. L. Jr
    Clinical Research (1987)

    Fulltext@MSK | Save
  • Combination intravenous (IV) and intraperitoneal (IP) 5-fluorouracil (5-FU) therapy of malignant disease principally confined to the peritoneal cavity (PC)
    Meeting Abstract

    Reichman, B.; Markman, M.; Hakes, T.; Rubin, S.; Hoskins, W.; Lewis, J. L. Jr
    Clinical Research (1987)

    Fulltext@MSK | Save

    • SLACK, Inc. – authorized name for: